Produktinformation
GSK2850163 is a small molecule that has been identified by GSK as a potential drug target for cancer. The compound inhibits the AMP-activated protein kinase, which is involved in cell growth and proliferation. GSK2850163 has been shown to inhibit the uptake of glucose in human muscle cells, which may be due to its ability to form hydrogen bonds with microenvironmental molecules. The compound also binds to the endoplasmic reticulum and prevents the hydrolysis of ATP, which leads to an increase in intracellular calcium levels. GSK2850163 has also been shown to have an effect on brucella bacteria. It can be used as a potential drug treatment for lymphocytic leukemia, as it blocks the growth of myeloid cells that are responsible for this disease.
Chemische Eigenschaften
Technische Anfrage zu: 3D-WJD98991 GSK2850163
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
